ArticleThe Journal of biological chemistry2011

Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.

Kangdong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.